Royalty Pharma Dividend
Dividend criteria checks 3/6
Royalty Pharma is a dividend paying company with a current yield of 3% that is well covered by earnings. Next payment date is on 14th June, 2024 with an ex-dividend date of 16th May, 2024.
Key information
3.0%
Dividend yield
32%
Payout ratio
| Industry average yield | 2.4% |
| Next dividend pay date | 14 Jun 24 |
| Ex dividend date | 16 May 24 |
| Dividend per share | n/a |
| Earnings per share | US$2.54 |
| Dividend yield forecast in 3Y | 3.3% |
Recent dividend updates
Recent updates
Unpleasant Surprises Could Be In Store For Royalty Pharma plc's (NASDAQ:RPRX) Shares
Apr 25
Is Royalty Pharma (NASDAQ:RPRX) Using Too Much Debt?
Apr 04Royalty Pharma's (NASDAQ:RPRX) Earnings Are Weaker Than They Seem
Feb 22Royalty Pharma: Solid Operational Performance
Feb 19Royalty Pharma (NASDAQ:RPRX) Will Pay A Larger Dividend Than Last Year At $0.21
Jan 31Royalty Pharma: One Of The Best Names In Pharmaceuticals
Jan 22Royalty Pharma plc's (NASDAQ:RPRX) Share Price Matching Investor Opinion
Dec 26Royalty Pharma's (NASDAQ:RPRX) Upcoming Dividend Will Be Larger Than Last Year's
May 12Royalty Pharma (NASDAQ:RPRX) Is Increasing Its Dividend To $0.20
Apr 20Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be Increased To $0.20
Jan 16Royalty Pharma to co-fund development of schizophrenia drug with Merck
Oct 12Royalty Pharma: Strategic Royalty Interest Acquisition To Drive Significant Growth
Aug 18Royalty Pharma declares $0.19 dividend
Jul 15Royalty Pharma: Unique Diversification, Bear Market Performer
May 26The Price Is Right For Royalty Pharma plc (NASDAQ:RPRX)
Apr 25Royalty Pharma Offers A Unique Long-Term Investment Opportunity
Mar 01Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be Increased To US$0.19
Jan 25Upcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, RPRX has been paying a dividend for less than 10 years.
Growing Dividend: RPRX's dividend payments have increased, but the company has only paid a dividend for 4 years.
Dividend Yield vs Market
| Royalty Pharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (RPRX) | 3.0% |
| Market Bottom 25% (US) | 1.5% |
| Market Top 25% (US) | 4.7% |
| Industry Average (Pharmaceuticals) | 2.4% |
| Analyst forecast in 3 Years (RPRX) | 3.3% |
Notable Dividend: RPRX's dividend (3%) is higher than the bottom 25% of dividend payers in the US market (1.54%).
High Dividend: RPRX's dividend (3%) is low compared to the top 25% of dividend payers in the US market (4.73%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (31.6%), RPRX's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (57.5%), RPRX's dividend payments are covered by cash flows.